12.01.2015 Views

In vitro quantitation of Theileria parva sporozoites for use - TropMed ...

In vitro quantitation of Theileria parva sporozoites for use - TropMed ...

In vitro quantitation of Theileria parva sporozoites for use - TropMed ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

70 Chapter 5: Snap freezing <strong>of</strong> <strong>Theileria</strong> <strong>parva</strong> stabilates<br />

______________________________________________________________________________________________<br />

5.2. Materials and Methods<br />

5.2.1. Stabilate preparations<br />

Three stabilates <strong>of</strong> T. <strong>parva</strong> were produced as described in the OIE manual (2005). Briefly,<br />

R. appendiculatus ticks were infected as nymphs with the T. <strong>parva</strong> Katete stock (Berkvens et<br />

al.,1988; Geysen et al., 1999) and allowed to moult in an incubator at 22°C and 85% relative<br />

humidity. Eight weeks later, the resultant adult ticks were fed on rabbits <strong>for</strong> four days to induce<br />

sporogony <strong>of</strong> the parasite. The ticks were ground <strong>for</strong> 15 min in a mortar and pestle using crushed<br />

glass in RPMI 1640 (25 mM HEPES), at a concentration <strong>of</strong> 20 ticks/ml supplemented with 3.5%<br />

(w/v) BSA. The resulting material was centrifuged and the supernatant divided into three lots. To<br />

each lot was added an equal volume <strong>of</strong> chilled RPMI 1640/BSA containing glycerol 15% (w/v),<br />

sucrose (0.6 M) or trehalose (0.2 M). Glycerol solution was added drop-wise. The extracts were<br />

stirred continuously in an ice bath during addition <strong>of</strong> cryopreservatives. Three stabilate suspensions<br />

with final concentrations <strong>of</strong> 7.5 % glycerol, 0.3 M sucrose and 0.1 M trehalose were prepared.<br />

Suspensions were diluted to a final concentration <strong>of</strong> 1 tick/ml, keeping cryoprotectant<br />

concentrations constant and aliquoted into 1.5 ml Nalgene ® cryogenic vials (1 ml/vial). Vials were<br />

then placed in an ultra-freezer <strong>for</strong> 24 h be<strong>for</strong>e plunging in liquid nitrogen until <strong>use</strong>. The different<br />

freezing protocols were applied on the stabilate after thawing from cryopreservation. Such stabilates<br />

have been found to lose some infectivity but the procedure is a good way <strong>of</strong> reducing variability in<br />

infectivity stemming from different stabilate storage vials (see chapter 6).<br />

5.2.2. Freezing<br />

Vials <strong>of</strong> each <strong>of</strong> the three stabilates were thawed at 37°C <strong>for</strong> 5 min, pooled and centrifuged in a 50<br />

ml Cellstar ® tube (Greiner Bio-One, Frickenha<strong>use</strong>n, Germany) at 400 g <strong>for</strong> 10 min. This was to<br />

remove any yeast and fungi that could be present (Marcotty et al., 2004). The supernatants were<br />

then re-aliquoted into fresh Nalgene ® vials at 0.5 ml/vial and refrozen by the following methods: (a)<br />

placed in an ultra freezer <strong>for</strong> 24 h be<strong>for</strong>e plunging in liquid nitrogen (current method <strong>use</strong>d in<br />

stabilate production), (b) controlled freezing in a programmed freezer (Minicool ® 40 PC, Air<br />

Liquide, France) at 1 ºC/min till -40 ºC and then at 5 ºC/min till -100 ºC be<strong>for</strong>e plunging in liquid<br />

nitrogen and (c) snap freezing by plunging the vials directly in liquid nitrogen. All vials were kept<br />

on ice be<strong>for</strong>e freezing. There was an equilibration period <strong>of</strong> 10 min between aliquoting and<br />

freezing. The stabilates were held in liquid nitrogen <strong>for</strong> 24 h.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!